MedPath
HSA Approval

CALCIUM GLUCONATE INJECTION USP 10%

SIN08451P

CALCIUM GLUCONATE INJECTION USP 10%

CALCIUM GLUCONATE INJECTION USP 10%

November 24, 1995

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

A12AA20

calcium (different salts in combination)

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

AMERICAN PHARMACEUTICAL PARTNERS INC

Active Ingredients

CALCIUM GLUCONATE

94 mg/ml

Calcium gluconate

CALCIUM SACCHARATE TETRAHYDRATE

4.5 mg/ml

Gatifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CALCIUM GLUCONATE INJECTION USP 10% - HSA Approval | MedPath